MarketLens

Why Did Raymond James Downgrade BridgeBio Pharma

2 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Executive Chair's $1 Million Sale: A Hidden Warning for Raymond James Financial

3 weeks ago

Why Did Bank of America Downgrade Qualcomm

5 months ago

Why Did Goldman Sachs Downgrade BioArctic

3 months ago

Why Did Goldman Sachs Double Downgrade Best Buy

4 months ago

Raymond James: Turning Bullish After Earnings Preview And Investor Day (Upgrade)

Raymond James Financial was upgraded to Buy after an earnings preview and Investor Day 2026. The analyst expects 3QFY26 EPS to beat consensus, driven by Capital Markets and Private Client Group outper...

Stock News•1 months ago

BridgeBio Oncology Therapeutics: KRAS Program Data Due 2H26 May Reignite Bullish Sentiment

BridgeBio Oncology Therapeutics fell >30% since prior coverage, but remains a Buy with BB-8520 showing 65% ORR and 100% DCR in KRAS G12C NSCLC. Mature data readouts due 2H26 could be key catalysts.

BBOT

Stock News•1 months ago

Why This Pharmaceutical Stock Jumped Close to 100% This Week

Shares of a pharmaceutical stock surged nearly 100% this week after agreeing to be acquired by a larger sector firm.

CRNX

Stock News•1 months ago

This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

HCA Healthcare was downgraded by a top analyst on Wednesday, joining four other major names losing bullish ratings. The downgrades reflect shifting analyst sentiment across healthcare and other sector...

HCA